Source: The Company of Biologists Rare diseases affect only a few people in a given population but, collectively, they impact over 400 million people globally
Source: Polite On Society Greetings, everyone. Diversity in medicine in today’s society is important. This week, we hear from Dr. Harsha Rajasimha, Ph.D., Founder and
Source: PRWeb The Food and Drug Administration has approved 16 new gene therapies to date, but for most people around the world, these expensive treatments
Source: PRWeb The cost of patients dropping out of clinical trials continues to be a major problem for the development of new drugs and treatments
Source: PRWeb Dr. Harsha Rajasimha, Founder and CEO of Jeeva Trials, highlights the importance and value of Investigator-Initiated Trials (IITs) in gathering real-world data on
Source: Onco’Zine The Inflation Reduction Act of 2022 (IRA) covers new and reinstated tax laws that will affect individuals and businesses. Through IRA, President Joe
Source: PRWeb Drug pricing controls imposed by the Inflation Reduction Act of 2022 may appear positive for patients in the short term. However, these controls
Source: EIN News CCF grants support startups, critical early technology testing and market validation efforts. RICHMOND, VIRGINIA, UNITED STATES, June 27, 2023/EINPresswire.com/ — The Virginia
Source: Cision PRweb The FDA has released new guidance for decentralized clinical trials (DCTs) for drugs, biological products, and medical devices to improve DCT implementation.
Source: PR Distribution Genomics expert and social entrepreneur, Harsha Rajasimha, looks to bridge OMICS and Exposure Health with partner DailyBreath at the inaugural total exposure
